|
|||||
|
|
Comparative rates of adverse events with different formulations of intravenous iron |
|
| Authors: | Maureen M. Okam Elyse Mandell Nathanael Hevelone Rachel Wentz Ainsley Ross Gregory A. Abel |
| Affiliation: | 1. Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts;2. Department of Medical Oncology, Dana‐Farber Cancer Institute, Boston, Massachusetts;3. Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts;4. Division of Population Sciences, Department of Medical Oncology, Dana‐Farber Cancer Institute, Boston, Massachusetts;5. Center for Leukemia, Department of Medical Oncology, Dana‐Farber Cancer Institute, Boston, Massachusetts |
| Abstract: | |
| Keywords: | |